Topic: Associate Professor Peter Gilling

Topic type:

Urologist, Head of Clinical School at Tauranga Hospital.

 Tauranga-based Peter Gilling is leading the world in urology research and cutting-edge techniques, including the use of the Holmium Laser and most recently robotics, to treat enlarged prostates (BPH), a very common disorder that affects 40 per cent of 80 year-old

men.Ass. Prof Peter Gilling

“Compared to the procedure I trained in, the so called TURP (Trans Urethral Section of the Prostate), we developed a laser procedure which results in a shorter hospital stay – typically overnight as opposed to sometimes several days. There are fewer complications, so it’s safer and it’s long lasting. Once this procedure is done, it stays done. So it’s better, quicker and it’s safer,” says Peter.

In 1993, Peter and fellow urologist Mark Fraundorfer established Venturo, a unique public/private partnership model which allowed the clinicians to take decisions and invest in research and technologies.

“The research that was done here in Tauranga Hospital through the 1990’s has changed the way people do this procedure throughout the world. Venturo has played a very important part in my ability to do high quality research in the field of urology, which has put Tauranga on the map.

“Through Venturo, Mark and I have been able to introduce many procedures to treat a lot of different conditions, including enlarged and cancerous prostates, to the Bay of Plenty and New Zealand. Holmium Laser therapies, many key-hole surgery techniques, Aquablation (which uses water instead of lasers), Brachytherapy (which involves placing radioactive seeds into the prostate) and Cryo-therapy (which freezes kidney and prostate tumours) are some of these. Tauranga also got the first surgical robot in the country used for treating prostate cancer initially. This has only been possible in the private sector so far, but there is an expectation that we will be able to provide that service to public patients in the future.”

“Our procedure and technique (known as HoLEP) is being used worldwide now. Over 300 hospitals in Japan use it, it’s being used widely in Korea and China, throughout Europe and it’s very commonly done in the UK and more recently in Australia and the USA.” 

Peter Gilling operating 

Cyro-therapy probes in place in a patient's kidney. 

Peter Gilling using Cyro-therapy on a kidney 


Peter Gilling using Cyro-therapy on a kidney

Discuss This Topic

There are 0 comments in this discussion.

join this discussion


Tags: Innovators

Associate Professor Peter Gilling

First Names:Peter
Last Name:Gilling